Therapeutic drug monitoring of TNFinhibitors and other therapeutic antibodies.
Develop assays for novel immunotherapy drugs such as pembrolizumab, nivolumab and ipilimumab for monitoring drug levels in patients with lung cancer and malignant melanoma.
Develop assays for measuring rituximab and anti-rituximab for monitoring drug level and anti-drug antibody formation.
Detection of antibodies to transglutaminase in the HUNT4-cohort using an in-house dual label assay in collaborative study “Coeliac disease in HUNT”.
Screening for patient antibodies to HH1, a novel antibody-based drug used in lymphoma clinical trials (Lymrit).
Gehin JE, Klaasen RA, Klami Kristianslund E, Jyssum I, Sexton J, Warren DJ, Aletaha D, Haavardsholm EA, Syversen SW, Goll GL, Bolstad N(2024) Therapeutic serum level for adalimumab in rheumatoid arthritis: explorative analyses of data from a randomised phase III trial RMD Open, 10(4) DOI 10.1136/rmdopen-2024-004888, PubMed 39537558
Askeland FB, Frøen HM, Bolstad N, Thorsby PM, Schjesvold F, Wammer ACP, Følling I, Tjønnfjord GE(2024) Monoclonal Insulin Autoimmune Syndrome Successfully Treated With Plasma Cell Directed Therapy Clin Lymphoma Myeloma Leuk(in press) DOI 10.1016/j.clml.2024.10.005, PubMed 39500643
Kawano-Dourado L, Kristianslund EK, Zeraatkar D, Jani M, Makharia G, Hazlewood G, Smith C, Jess T, Stabell C, Schatten A, Owen A, Gehin J, Katsidzira L, Weinberg D, Bauer-Ventura I, Tugwell P, Moayyedi P, Cecchi AVW, Shimabuco A, Seterelv S, Gyuatt G, Agoritsas T, Vandvik PO(2024) Proactive therapeutic drug monitoring of biologic drugs in adult patients with inflammatory bowel disease, inflammatory arthritis, or psoriasis: a clinical practice guideline BMJ, 387, e079830 DOI 10.1136/bmj-2024-079830, PubMed 39467592